RJA
MSB

Raymond James & Associates’s Mesabi Trust MSB Stock Holding History

Raymond James & Associates’s Portfolio MSB Stock Details MSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$409K Buy
18,064
+2,043
+13% +$37.4K ﹤0.01% 3221
2024
Q2 		$276K Sell
16,021
-5,893
-27% -$102K ﹤0.01% 3423
2024
Q1 		$388K Sell
21,914
-3,188
-13% -$60.5K ﹤0.01% 3222
2023
Q4 		$514K Sell
25,102
-2,223
-8% -$44K ﹤0.01% 2944
2023
Q3 		$548K Buy
27,325
+8,450
+45% +$162K ﹤0.01% 2832
2023
Q2 		$385K Sell
18,875
-1,923
-9% -$41.3K ﹤0.01% 3092
2023
Q1 		$524K Buy
20,798
+6,288
+43% +$146K ﹤0.01% 2893
2022
Q4 		$261K Sell
14,510
-493
-3% -$9.78K ﹤0.01% 3300
2022
Q3 		$323K Sell
15,003
-1,494
-9% -$38.5K ﹤0.01% 3133
2022
Q2 		$405K Buy
16,497
+2,447
+17% +$63.6K ﹤0.01% 3041
2022
Q1 		$374K Buy
14,050
+675
+5% +$19K ﹤0.01% 3259
2021
Q4 		$353K Sell
13,375
-13,610
-50% -$364K ﹤0.01% 3342
2021
Q3 		$802K Buy
26,985
+248
+0.9% +$8.29K ﹤0.01% 2728
2021
Q2 		$946K Buy
+26,737
New +$967K ﹤0.01% 2620

Other funds holding MSB

HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
V
ValueWorks New York $479M AUM 117.71% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
BCM
Beddow Capital Management Jackson, Wyoming $265M AUM 18.36% 1-Year Est. Return
MRI
Mad River Investors Boston, Massachusetts $268M AUM 31.54% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $745M AUM 23.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Raymond James & Associates's MSB Position: Q3 2024 in Review

Raymond James & Associates increased its Mesabi Trust (MSB) stake by 13% in Q3 2024, buying an estimated $37.4K and bringing the position to 18,064 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

Raymond James & Associates first reported a position in MSB in Q2 2021 and has held it in 14 quarters since. The position peaked at $946K in Q2 2021. 47 funds tracked by Wall St. Rank hold MSB as of Q3 2024.

  • Raymond James & Associates held 18,064 shares of Mesabi Trust worth $409K as of Q3 2024.
  • Raymond James & Associates bought 2,043 Mesabi Trust shares in Q3 2024, an estimated $37.4K.
  • Mesabi Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3221 holding.
  • Raymond James & Associates first reported a position in Mesabi Trust in Q2 2021 and has held it in 14 quarters since.
  • Raymond James & Associates's Mesabi Trust position peaked at $946K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Mesabi Trust as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.